MedCity News May 26, 2025
In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups. Our roundup of regulatory news includes notable firsts for Alzheimer’s diagnosis and migraine treatment.
When Covid-19 vaccines roll out for the fall and winter respiratory illness season, they will continue to be based on the same lineage that is the basis for vaccines from this past season, but tweaked to address the variant that is currently prevalent in the U.S. and some other parts of the world.
An advisory committee to the FDA last week voted to recommended monovalent vaccines based on the...
Today's Sponsors
Today's Sponsor